Increase in patients suffering from rheumatoid arthritis and osteoarthritis is expected to drive the growth of global ibuprofen market during the forecast period.
According to TechSci Research report, “Global Ibuprofen Market By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations (CMO), In-House), By End User (Hospitals, Clinics, Others), By Distribution Channel (Offline v/s Online), By Region, By Company, Competition, Forecast & Opportunities, 2026”, Global Ibuprofen Market was valued USD4981.02 million in value terms in 2020 and is forecast to grow at a CAGR of 5.67% and reach USD6945.36 million by 2026. Rising awareness regarding rapid pain relief injections is one of the major factors accounting for the growth of global ibuprofen market. Moreover, occurrence of diverse range of diseases such as cardiovascular disease, diabetes, infectious diseases, and kidney-related complications is expected to aid well for the growth of global ibuprofen market through the forecast period.
In addition to this, increased development of innovative drugs by major pharmaceutical companies is expected to positively influence the growth of global Ibuprofen market in the years to come. Along with this, easy product availability coupled with extensive supply and distribution networks are expected to positively contribute to the market growth in the next 5 years. However, there are certain factors that might act as major impediments to the growth of global Ibuprofen market during the forecast period such as various side effects of intravenous ibuprofen injections.
Browse 112 market data Figures spread through over 110 Pages and an in-depth TOC on “Global Ibuprofen Market”
Global ibuprofen market can be segmented based on product type, route of administration, application, age group, source, end user, distribution channel, company, and region. The product type segment is further classified into tablet, capsule, syrup, and injection. The tablet segment is dominating the market due to its higher application and low cost. The route of administration segment is further segregated into oral and intravenous. The oral segment is dominating the market and is expected to lead the global Ibuprofen market in the forecast period too. The oral segment includes Ibuprofen product type that is consumed orally such as tablet, capsule, and syrup, whereas route of administration of injection is intravenous.
Considering the application, the market is fragmented into rheumatoid arthritis and osteoarthritis, ankylosing spondylitis, inflammatory diseases, dysmenorrhea, and others. The rheumatoid arthritis segment is anticipated to dominate the market during the forecast period which is accredited to application of this drug in treating rheumatoid arthritis or any other type of inflammatory arthritis. Ibuprofen is as effective as Aspirin and other nonsteroidal anti-inflammatory drugs when given at a dose of 1,200 mg/day to treat rheumatoid arthritis. The safety and tolerability of Ibuprofen when compared to Aspirin are superior, which is further estimated to drive the segmental growth over the coming years.
The market’s growth will be fueled by factors such as increasing healthcare spending, growing incidences of arthritis, rising cancer cases, widening urbanization, and rising analgesic drug sales.
BASF SE, IOL Chemicals & Pharmaceuticals Ltd., Mallinckrodt plc, Lupin Pharmaceuticals, Inc., Cumberland Pharmaceuticals Inc., Shandong Xinhua Pharmaceutical Company Limited, Hubei Biocause Phamaceutical Co., Ltd., Perrigo Company PLC, Strides Pharma Science Limited, Amneal Pharmaceuticals, Inc., Pfizer Inc., Johnson & Johnson, Teligent, Inc., Solara Active Pharma Sciences Ltd., Abbott Laboratories Ltd. among others are the leading players operating in global ibuprofen market. The leading players are adopting several growth strategies to enhance the market scenario of Ibuprofen. Other competitive strategies include product launches; mergers & acquisitions; agreements, partnerships, and research collaborations; and expansions to diverse their product portfolio in order to strengthen their market position.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7235
customers can also request for 10% free customization on this report.
North America is forecast to dominate the global ibuprofen market in the next 5 years on account of changes in healthcare facilities, increasing demand for ibuprofen due to the side effects of opioid analgesics such as respiratory depression, allergic reactions, sedation, and gastrointestinal incidents, increasing research and development activities to produce new drugs, and rising prevalence of chronic diseases. Asia pacific region is forecast to register highest growing CAGR over the years to come which can be attributed to an increase in people in the elderly age group. Additionally, China is the largest supplier of Ibuprofen, contributing about 33% of market share and India is the second largest supplier of Ibuprofen. This is further expected to boost the market share.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Ibuprofen Market, By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations (CMO), In-House), By End User (Hospitals, Clinics, Others), By Distribution Channel (Offline v/s Online), By Region, By Company, Competition, Forecast & Opportunities, 2026” has evaluated the future growth potential of global ibuprofen market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global ibuprofen market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]